Inactive Instrument

Camlin Fine Sciences Ltd Stock NSE India S.E.

Equities

Specialty Chemicals

End-of-day quote NSE India S.E.
- - Intraday chart for Camlin Fine Sciences Ltd
Sales 2024 * 16.47B 198M 0 Sales 2025 * 21.79B 261M 0 Capitalization 18.2B 218M 0
Net income 2024 * -95M -1.14M - Net income 2025 * 984M 11.8M - EV / Sales 2024 * 1.1 x
Net cash position 2024 * - 0 - Net cash position 2025 * - 0 - EV / Sales 2025 * 0.84 x
P/E ratio 2024 *
-181 x
P/E ratio 2025 *
17.2 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 55.2%
More Fundamentals * Assessed data
Transcript : Camlin Fine Sciences Limited, Q3 2024 Earnings Call, Feb 09, 2024
Camlin Fine Sciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Transcript : Camlin Fine Sciences Limited, Q2 2024 Earnings Call, Nov 06, 2023
Camlin Fine Sciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Camlin Fine Sciences Limited Appoints Nilesh Jadhav as Chief Operating Officer CI
Transcript : Camlin Fine Sciences Limited - Shareholder/Analyst Call
Camlin Fine Sciences Arm Extends Closure of Diphenol Plant in Italy MT
Infinity Direct Holdings and Infinity Direct Holdings Sidecar I completed the acquisition of 9.7% stake in Camlin Fine Sciences Limited for INR 2.7 billion. CI
Camlin Fine Sciences Unit Shuts Diphenol Plant in Europe MT
Camlin Fine Sciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Univar Solutions Named Authorized Distributor for Camlin Fine Sciences' Aroma Ingredients in US, Canada MT
Camlin Fine Sciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Camlin Fine Sciences Limited Announces Mr. Sarvjit Bedi Resigns as Non-Executive Director CI
Infinity Direct Holdings and Infinity Direct Holdings Sidecar I made an offer to acquire 26% stake in Camlin Fine Sciences Limited for INR 7.1 billion. CI
Camlin Fine Sciences Limited Announces the Resignation of Thomas Videbæk as Non-Executive Independent Director, Effective February 23, 2023 CI
More news
Managers TitleAgeSince
Chief Executive Officer 58 14-08-03
Chief Executive Officer 61 07-01-10
Director of Finance/CFO - 17-02-09
Members of the board TitleAgeSince
Director/Board Member 64 20-09-28
Chief Executive Officer 61 07-01-10
Director/Board Member 59 20-02-06
More insiders
Camlin Fine Sciences Limited is an India-based company, which is engaged in research, development, manufacturing and marketing of specialty chemicals, ingredients, and additive blends. The Company is a provider of diverse advanced antioxidants and shelf-life extensions, aroma ingredients, performance chemical products and related solutions for food, animal nutrition, pet food, pharmaceutical and petrochemical industries globally. Its products include TBHQ, Catechol, BHA, 4-Tertiary Butyl Catechol, Xtendra, Butylated Hydroxy Toluene, Guaiacol, Para DiMethoxy Benzene, NaSure, MEHQ, Ascorbyl Palmitate, and HQEE. The Company manufactures specialty chemicals that can be categorized into shelf-life solutions, performance chemicals, aroma ingredients and health and wellness. Its products are used in varied industries, such as human food, animal feed, pet food, agrochemicals, petrochemicals, pharmaceuticals, nutraceuticals, flavors and fragrances and health care.
More about the company